Allurion’s swallowable balloon leads to 13% weight reduction in teens
Amid the hype of weight loss pills, Allurion is pushing ahead with its swallowable balloon – with the company reporting…
Amid the hype of weight loss pills, Allurion is pushing ahead with its swallowable balloon – with the company reporting…
Fractyl Health has reported positive results for its hydrothermal ablation device Revita, as the company looks to battle the booming…
Vivani Medical has announced plans to start the first clinical study of its investigational six-month glucagon-like peptide 1 (GLP-1) implant…
Roche has secured the CE Mark for its Accu-Chek SmartGuide, an AI-enabled continuous glucose monitoring (CGM) solution. This approval enables…
Insulet is looking to expand the use of its tubeless insulin pump, Omnipod 5 automated insulin delivery system (Omnipod 5),…
The US Food and Drug Administration (FDA) has granted authorisation for CamDiab’s adaptive hybrid closed-loop CamAPS FX app, marking a…
Click Therapeutics, a medical technology company, has announced the acquisition of assets from Better Therapeutics, aiming to enhance its development…
The US Food and Drug Administration (FDA) has issued a Class I recall, the most serious designation for a medical…
Alongside the ever-growing pharma revolution in weight loss drugs, BariaTek Medical is one of the medtech companies making sure device…
New Jersey-based GlucoTrack has completed the first preclinical study with its implantable continuous glucose monitor (CBGM) and is preparing for…